ADC Therapeutics SA (ADCT) Earnings Date & Reports
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ADCT is expected to report earnings to rise 77.21% to -33 cents per share on March 12
Q4'25
Est.
$-0.34
Q3'25
Beat
by $0.17
Q2'25
Beat
by $0.14
Q1'25
Beat
by $0.18
Q4'24
Beat
by $0.18
The last earnings report on November 10 showed earnings per share of -18 cents, beating the estimate of -36 cents. With 187.48K shares outstanding, the current market capitalization sits at 501.70M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ADCT showed earnings on November 10, 2025. You can read more about the earnings report here.